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Isolation and characterization of the chicken erythroid anion transporter (band 3) cDNA clone, pCHB3-1,
revealed that the chicken erythroid band 3 polypeptide is 844 amino acids in length with a predicted mass of
109,000 daltons. This polypeptide is composed of a hydrophilic N-terminal cytoplasmic domain and a
hydrophobic C-terminal transmembrane domain. The -90 N-terminal amino acids of the human and murine
erythroid band 3 polypeptides are absent in the predicted sequence of the chicken erythroid band 3
polypeptide. The absence of this very acidic N-terminal region is consistent with the lack of binding of
glyceraldehyde-3-phosphate dehydrogenase to chicken erythroid band 3, as weH as the relatively basic
isoelectric point observed for this molecule. The remainder of the cytoplasmic domain shows little similarity to
the cytoplasmic domain of the murine and human erythroid band 3, with the exception of the putative
ankyrin-binding site, which is highly conserved. In contrast, the transmembrane domain of the chicken band
3 polypeptide is very similar to that of the murine erythroid and human nonerythroid band 3 polypeptides. The
transmembrane domain contains 10 hydrophobic regions that could potentially traverse the membrane 12 to
14 times. In addition, a variant of chicken erythroid band 3, pCHB3-2, was cloned in which one of the
hydrophobic regions of pCHB3-1 is lacking. The transcript complementary to pCHB3-2 accumulated in
chicken erythroid ceUs in a similar manner as the transcript complementary to pCHB3-1 during embryonic
development. This is the first example of a transporter protein or ion channel with alternative primary
structures in its membrane-spanning segments.
The anion transporter, also known as band 3, is the
predominant integral membrane protein of mammalian (44)
and avian (12, 22) erythroid cells. Biochemical and physio-
logical studies have indicated that the band 3 polypeptide
possesses multiple functions that are segregated into two
distinct domains. The C-terminal membrane-spanning region
of band 3 mediates anion transport, primarily the one-for-
one exchange of chloride for bicarbonate (28). This rapid,
electroneutral exchange process increases the C02-carrying
capacity of the blood as well as stabilizes the extracellular
pH (14). The N-terminal cytoplasmic region of band 3
provides the membrane attachment site for the erythrocyte
membrane cytoskeleton through its interaction with ankyrin
(3, 21), protein 4.1 (40), and protein 4.2 (11). The extreme N
terminus of the cytoplasmic domain also possesses high-
affinity binding sites for hemoglobin (10) and the glycolytic
enzymes aldolase (38) and glyceraldehyde-3-phosphate de-
hydrogenase (47, 52), although the latter is absent in both the
murine (30) and chicken (22) band 3 polypeptide. In addition
to the functionally analogous erythroid band 3 polypeptides
that have been described in many species, immunological
studies have demonstrated band 3-like polypeptides in a
variety of nonerythroid tissues (12, 16, 27).
The recent isolation and characterization of cDNA clones
for the murine erythroid (30) and human nonerythroid (15)
band 3 polypeptides have revealed several features of band 3
that are conserved. The predicted sequences of the trans-
membrane domains of the murine erythroid and human
nonerythroid band 3 polypeptides are very similar to each
other and to the transmembrane regions of the human
erythroid band 3 polypeptide that have been sequenced (8,
35). The hydropathy profile of these polypeptides reveals 10
very hydrophobic regions that have been proposed to span
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the membrane as many as 12 times (30). Characterization of
the murine band 3 gene (29) has indicated that each of these
hydrophobic membrane-spanning segments roughly corre-
sponds to an exon of the band 3 gene. The predicted
sequence of the cytoplasmic domain of the murine erythroid
band 3 polypeptide is also very similar to those regions of the
cytoplasmic domain of the human erythroid band 3 polypep-
tide that have been sequenced (26), although the sequence
has diverged at the extreme N terminus where the binding
sites for the glycolytic enzymes are located in the human
molecule (38, 47). Both the murine and human erythroid
band 3 polypeptides have relatively little similarity to the
predicted sequence of the cytoplasmic domain of the human
nonerythroid band 3 polypeptide. However, the region of the
cytoplasmic domain where the ankyrin-binding site has
tentatively been placed (34) exhibits considerable homology
among all the band 3 polypeptides, suggesting that this
high-affinity binding site is conserved in erythroid and non-
erythroid cell types.
We describe here the isolation and characterization of a
cDNA clone, pCHB3-1, for chicken erythroid band 3. These
studies revealed that the transmembrane domain of the
chicken erythroid band 3 polypeptide is greater than 70%
identical to the membrane-spanning region of the band 3
polypeptides from other species. The hydropathy profile
suggests that chicken erythroid band 3 traverses the mem-
brane 12 to 14 times, in agreement with previous results (15,
30). Furthermore, many of the amino acids implicated in
anion transport through drug binding studies are conserved
in the chicken erythroid band 3 polypeptide. Sequence
analysis in conjunction with in vitro transcription and in
vitro translation studies indicates that the -90 N-terminal
amino acids of human (26) and murine (30) erythroid band 3
are absent in chicken erythroid band 3. The lack of this
cytoplasmic region is consistent with the absence of binding
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of chicken erythroid band 3 to glyceraldehyde-3-phosphate
dehydrogenase (22). The remainder of the cytoplasmic do-
main is only -40% similar to the cytoplasmic domain of
murine erythroid band 3, although the region where the
ankyrin-binding site has tentatively been placed is highly
similar, suggesting that this site in the band 3 polypeptide is
conserved in all species. Finally, an additional band 3
cDNA, pCHB3-2, was isolated that encodes a variant
chicken erythroid band 3 polypeptide lacking one of the
putative transmembrane-spanning segments found in
pCHB3-1. Si nuclease analysis indicated that the RNA
complementary to pCHB3-2 accumulates in erythroid cells
during development in a manner similar to that previously
reported for the RNA complementary to pCHB3-1 (13).
Interestingly, the boundaries of the region that is absent in
the RNA complementary to pCHB3-2 almost exactly corre-
spond to two of the intron-exon splice junctions of the
murine band 3 gene (29). This suggests that the equivalent of
murine exon 15 (29) is removed from this transcript by
alternative splicing. This represents the first report of a
transporter protein or ion channel with an alternative pri-
mary structure in its membrane-spanning segments.
MATERIALS AND METHODS
Isolation and characterization of band 3cDNA clones. A
Xgtll cDNA library constructed with poly(A)+ RNA from
erythroid cells isolated from 15-day-old chicken embryos
(37) was screened with the nick-translated (42) insert of the
previously described band 3 cDNA clone, p3(9-1) (12).
Filters were prepared and hybridized as described previ-
ously (4), and cDNA inserts from positive clones were
isolated and subcloned into the pGEM-3 vector (Promega
Biotec, Madison, Wis.). The restriction endonuclease sites
within the cDNA inserts were determined by single and
double digests with various restriction endonucleases, and
the digestion products were resolved on agarose gels.
DNA sequencing. The cDNA inserts from band 3-positive
clones were also subcloned into M13mpl9, and both strands
were sequenced by the dideoxy chain termination method
(43). Oligonucleotide primers for sequencing reactions and
primer extension analysis were synthesized on an automated
DNA synthesizer at the California Institute of Technology
microchemical facility.
Primer extension analysis. An oligonucleotide primer cor-
responding to nucleotides -690 to -671 of pCHB3-1 (Fig. 1)
was end labeled with T4 polynucleotide kinase in the pres-
ence of [-y-32P]ATP. A 10-pmol sample of this 32P-labeled
primer was hybridized to S ,ug of total RNA from erythroid
cells isolated from 5-day-old chicken embryos. The primer
was extended with reverse transcriptase by incubation at
42°C for 45 min in 30 mM Tris hydrochloride (pH 8.7)-5mM
MgCl2-2.5 mM dithiothreitol-3.0 mM KCl-350 p.M each
deoxynucleoside triphosphate. Labeled fragments were an-
alyzed on a 7 M urea-5% polyacrylamide gel, and the gel was
exposed to Kodak XAR-5 X-ray film at -80°C with an
intensifying screen.
Sl nuclease assays. S1 nuclease analyses were performed
essentially as described previously (39). The BgIIH-EcoRI
fragment of pCHB3-2 was end labeled with the large frag-
ment of DNA polymerase I in the presence of [a-
32P]deoxynucleoside triphosphates, while the XhoI-PvuII
fragment of pCHB3-2 was end labeled with T4 polynucleo-
tide kinase in the presence of [_y-32P]ATP. The end-labeled
fragments were hybridized with 2 x 106 cell equivalents
(reflecting recovery) of total erythroid RNA from 5-, 8-, 10-,
and 15-day-old chicken embryos, and the end-labeled BglII-
EcoRI fragment was also hybridized to 200 ng of poly(A)+
RNA from 5-day-old erythroid cells in 80% formamide-40
mM PIPES [piperazine-N,N'-bis(2-ethanesulfonic acid)]-0.4
M NaCl-1 mM EDTA for 12 h at 55°C. The samples were
digested with S1 nuclease (5) for 2 h at 30°C, and the
fragments were resolved on 7 M urea-5% polyacrylamide
gels. The gels were exposed to Kodak XAR-5 X-ray film at
-80°C with an intensifying screen.
Construction of pCHB3-lA and transcription in vitro. Ap-
proximately 5 jig of the band 3 cDNA clone, pCHB3-1, was
digested with the restriction endonuclease BamHI. The
resulting fragments were resolved on a low-melting-point
agarose gel, and the 5.7-kilobase fragment was isolated (49).
This fragment, which lacks the 716-base-pair (bp) BamHI
restriction fragment that extends from the BamHI site in the
polylinker to nucleotide -14 relative to the translational
initiation site of pCHB3-1, was religated with T4 DNA ligase
and used to transform HB101 cells. Positive colonies were
selected, and DNA was prepared. DNA (5 ,ug) from this
construct, pCHB3-1A, and 5,ug ofDNA from pCHB3-1 were
linearized with the restriction endonuclease BglI and used as
templates for in vitro transcription reactions with SP6 RNA
polymerase (36).
In vitro translations. Approximately 500 ng of RNA tran-
scribed in vitro from both pCHB3-1 and pCHB3-1A was
translated in vitro in a wheat germ extract (Amersham
Corp., Arlington Heights, Ill.) in the presence of 0.2 mCi of
[35S]methionine (1,200 to 1,400 Ci/mmol; Amersham Corp.)
per ml by incubation for 30 min at 25°C. The resulting
35S-labeled polypeptides were immunoprecipitated (13) with
a previously characterized band 3 antiserum (12). The band
3 immunoprecipitates were analyzed by electrophoresis on a
sodium dodecyl sulfate-15% polyacrylamide gel (33). The gel
was impregnated with 2,5-diphenyloxazole, dried, and ex-
posed to Kodak XAR-5 X-ray film at -80°C.
RNA isolation. Erythroid cells were isolated from 5-, 8-,
10-, and 15-day-old chicken embryos as described previously
(7). The cells were homogenized with a Dounce homogenizer
in a solution that contained 5 M guanidinium isothiocyanate,
50 mM Tris hydrochloride (pH 7.5), 50 mM EDTA, 5%
P-mercaptoethanol, and 3% sodium lauryl sarcosine. Homo-
genates were layered over a cushion of 5.7 M CsCl and
centrifuged as described previously (9). Poly(A)+ RNA was
isolated by oligo(dT)-cellulose chromatography (2).
RESULTS
Primary structure of chicken erythroid anion transporter.
A Xgtll cDNA library constructed with poly(A)+ RNA from
erythroid cells isolated from 15-day-old chicken embryos
was screened with a previously described erythroid anion
transporter (band 3) cDNA clone, p3(9-1), as a probe (12).
Additional cDNA clones were isolated, and one of these
clones, pCHB3-1, was shown to contain an insert of 3,448
bp. Subsequent studies revealed that pCHB3-1 encompasses
the entire coding region of chicken erythroid band 3 as well
as 705 bp of the 5' untranslated region and 177 bp of the 3'
untranslated region. Primer extension analysis indicated that
the band 3 mRNA extends -850 bases 5' of pCHB3-1,
consistent with a size of 4.3 kilobases for the RNA (12). The
nucleotide sequence of pCHB3-1 is presented in Fig. 1. A
single open reading frame extends from nucleotide 1 to
nucleotide 2532 and encodes a predicted polypeptide of 844
amino acids, which is significantly shorter than the 929
amino acids predicted for murine erythroid band 3 (30).
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-705 ACT ATC CCC ATC ATC CAC TTT CTT CTC TAA MAA AMA CCC AMA ACC TAC AMA ACA CAC ACA ACC ACT CT? CTA CAC CTA CTC CCC TCC CCC TAT CT? CTC TCA CCA ATC ATC ACA CCT CTA
-585 CCA TAT ACA AAC AAC TMA TAT TCC ACA AMA TCC TOC TAC ACA ACT CTC MAT CTC TTA ATC ATC TCC ACT AMA CCC TCT CTC CTA CTA CTC AT? CCA CAC CCT CCT AT? ACA TCA MAT CCC
-465 ACA CCA TCT CTA CCA AMA TCA CCT CTC ATC TAC TAC ACC AT? TAT TCA TTA CCC TCA ACT AT? TTC TAT TTA CMA ACT TCC TCC TTC TT? CAT CAC CCT CAT ACA AT? TCT CAC TCC TMA
-345 TTC TMA ATC CT? TTC CCA CMA CAT TTA AMA TCT ACA CTA ACT TTC AAC TCT CCA CCT CMA ACT ATC CMA ACA ATA TTA MAT AT? CCA CTC TAC GTC CAT AT? MAC ACC TCA CCC CTC MAA
-225 ACC TMA CTA CTC CCA TTA CAC TCT TCT CTA TTC TCC CTC CMA TCC ACA CAT CTT ATA AT? MAT ACT ATA ATA T?A MAT ATC CTA CMA ATA CMA TTC T?A CAC TMA ATC ACT CTC CCA TAC
-105 AAC CMA AT? CMA MAC ACC TCT CAC CT? CMA TCT CMA TAT TAT CTA CCT CTA CCC CAC ACC MCG CT? CAC CAC TTC CT? CT? CAC ACC ACC MCG CAT CCC TCC TCC AT? CAC CCC CCC CCCNet Clu Ala Cly Arg
10. 20 30 40
16 TCC CT? CAT CT? CAC CAC ACC AT? CAC CCC CCC CCC CCC TCC CCC ACC CAC CT? CCC CTC CT? ACC TAC CAC ACC CT? CTC CAC CT? CAC CCC CCC T?C CCC AMA CCC CT? CT? CT? CTC
Trp Leu His Leu Clu Clu Ser Net Clu Pro Cly Cly Ala Trp Cly Ser His Leu Pro Leu Leu Thr Tyr His Ser Leu Leu Clu Leu His Arg Ala Phe Al& Lys Cly Vol Val Leu Lou
50 60 70 80
136 CAC CT? CCC CCC ACC TCC CT? CCA CCC CT? CCC CAC CT? CT? CT? CAT CAC CTC AT? TAC CAC CCC CAC CT? MAC CCC CAC CAC CCC CAC CAC CT? CT? CCC CCC CT? CT? CT? CCC CAC
Asp Val Ala Ala Thr Ser Leu Ala Ala Val Ala His Val Leu Leu Asp Cln Leu Ilie Tyr Clu Cly Cln Lou Lys Pro Cln His Arg Asp Asp Val Leu Arg Ala Leu Leu Leu Arg His
90 100 110 120
256 MCG CAC CCC ACT CAC CCC CAC TCC CT? TCC ACC CT? CCC CCC CCC CAC CT? CAC TCC TCC CAC CCC CAC CAC MAC CAC CCC CAC CAC CCC CCA CT? CT? CCC CAC CAC CCC CCT GCT CAC
Lys His Pro Ser Clu Ala Clu Ser Val Trp Thr Leu Pro Ala Ala Cln Leu Cln Cys Ser Asp Cly Clu Cln Lys Asp Ala Clu Cln Arg Ala Leu Leu Arg Clu Cln Arg Ala Val Clu
130 140 150 160
376 AT? ACC CAC CT? CAT CCC CCC CCC CAC ACC CCC TCC ACC CCC CAC CT? CCC CCA CAC CT? CAC CAC CAC CT? CCC CAC CAC ACC CAC CCC ACC CT? CT? CT? CT? CCC TCC CCA CCC TTC
Met Arg Clu Leu His Cly Ala Cly Cln Ser Pro Ser Arg Ala Cln Leu Cly Pro Cln Leu His Cln Cln Lou Pro Clu Asp Thr Clu Ala Thr Lou Vol L,u Val Ala Cys Ala Ala Pho
170 180 190 200
496 CT? CAC CAC CCC CT? TT? CCC TT? CT? CCC CT? GCCC CCC CT? CTC CCC CAC CCC CT? CT? CCC CT? CCC CT? CCC CT? CCC TT? CT? CT? ACC CT? TT? CCC CCC CCA CAC CCC CCC CCT
Leu Clu Cln Pro Leu Leu Ala Leu Vol Arg Leu Ala Cly Lou Val Arg Asp Ala Val Lou Ala Val Pro Leu Pro Val Arg Pho Vol Leu Thr Val Leu Cly Pro Arg Cln Pro Ala Pro
210 220 230 240
616 CAC CTA CCA CCA CAT CCC CCC CCC CCC CCC ACC CTC AT? CCC CAC CCC CT? TT? CCC CCC CAC CCC TAC CT? TCC CCC CCC CCT CCC CAC CT? CT? CCC CCC CT? CAC CCC TTC CT? CAC
Cln Lou Pro Arg Asp Arg Arg Ala Ala Ala Thr Vol Not Ala Asp Arg Vol Ph. Arg Arg Asp Ala Tyr Leu Cys Cly Cly Arg Ala Clu Lou Lou Cly Cly Leu Cln Cly Phe Lou Clu250 260 270 280
736 CCC ACC AT? CT? CT? CCC CCC CMA CAC CT? CCC ACC CAC CAC CAC CT? CAT GCCC CT? AT? CCA CT? CAC CCC CAC CCT CT? CCC CCC CCC TAC CAC CAC CCC CAC ACC CT? CCC ACC CCC
Ala Ser Ile Vol Lou Pro Pro Cln Clu Vol Pro Sor Clu Cln His Leu His Ala Leu Ile Pro Leu Cln Arg His Ala Vol Arg Arg Arg Tyr Cln His Pro Asp Thr Vol Arg Thr Pro
290 300 310 320
856 CCC CCC CCC ACC CCC CCC AAA CAC ACA CCC CAT MAC GCCC CAC CCT CCC CAC CAC CAC CAC CCC CT? CT? CCC ACC ACC CCC CCC TT? CCC CCC TT? GCT ACC CAC AT? CCC CCC CCT TAC
Cly Cly Pro Thr Ala Pro Lys Asp Thr Cly Asp Lys Cly Cln Ala Pro Cln Asp Asp Asp Pro Leu Leu Arg Thr Arg Arg Pro Pho Cly Cly Leu Vol Arg Asp Ile Arg Arg Arg Tyr
330 340 350 360
976 CCC AMA TAC CT? ACT CAC AT? ACC CAT CCC CTC MAC CCC CAC TCC CT? CCA CCC CT? AT? T?C AT? TAC T?C CCA CCC CT? TCC CCC CCC AT? ACC T?C CCC CCT TT? CT? CCT CAC MAC
Pro Lys Tyr Leu Sor Asp Ile Arg Asp Ala Leu Ass Pro Cln Cys Leu Ala Ala Vol Ile Ph. Ile Tyr Ph. Ala Ala Vol Ser Pro Ala Ile Thr Ph. Cly Cly Leu Leu Cly Clu Lys
370 380 390 400
1096 ACC CCC CCT AT? AT? CCC CT? TCC CAC CT? CT? CT? TCC ACC ACC CT? CAC TCT TT? CT? TTC ACT CT? CT? ACC GCCC CAC CCT CT? CT? CT? CT? CCC T?C TCC CCC CCA CT? CT? CTC
Thr Arg Cly Not Not Cly Vol Ser Clu Leu Leu Leu Ser Thr Ser Vol Cln Cys Lou Leu Pho Sor Lou Leu Ser Ala Cln Pro Lou Lou Vol Vol Cly Pho Ser Cly Pro Leu Lou Vol
410 420 430 440
1216 TT? CAC CAC CCT TT? TT? ACC T?C TCT CAC CAT CAT CCC CT? CAC TAC AT? GCT GCCC CCC CT? TCC AT? CCC T?C TCC CT? AT? CT? CT? CT? CT? CT? GCGT?CT CCC TCC CAC CCC ACC
Ph. Clu Clu Ala Pho Pho Arg Ph. Cys Clu Asp His Cly Lou Clu Tyr Ile Vol Cly Arg Vol Trp Ile Cly Pho Trp Leu Ile Leu Leu Vol Lou Leu Vol Vol Ala Cys Clu Cly Sor
450 460 470 480
1336 GCT CT? CT? CCC TAC CT? TCC CCA TAC ACC CAC CAC AT? TT? TCC T?C CT? ATC TCC CTC ATC TT? AT? TAT CAC ACC TTC CCC AMA CT? CT? ACC AT? TT? CAC CCC CAC CCC CT? CAC
Vol Leu Vol Arg Tyr Lou Sor Arg Tyr Thr Cln Clu Ile Pho Sor Pho Lou Ile Sor Lou Ilo Pho Ile Tyr Clu Thr Pho Ala Lys Lou Vol Thr Ilo Lou Cln Ala His Pro Lou Cln
490 500 510 520
1456 CAC ACC TAC CAC ACC CAC CT? ACC ACC CAC CCC TCC CT? CCC AMA CCC MAC ACC CCC CT? CT? TCC CT? CT? CT? AT? CCC CCC ACC T?C T?C CTC CCC CT? TT? CT? CCT CAC TT? MAC
Cln Ser Tyr Asp Thr Asp Vol Sor Thr Clu Pro Ser Vol Pro Lys Pro Ass Thr Ala Leu Leu Ser Leu Vol Leu Not Ala Cly Thr Ph. Ph. Leu Ala Leu Ph. Leu Arg Cln Pho Lys
530 540 550 560
1576 MAC ACT CT? TT? CT? CCC CCC AAC GCT CCC CCC CT? AT? CCC CAC TTC CCC GCT CCC AT? TCC AT? TTC CT? AT? CCC CT? CCT CAC TT? TT? AT? MAC CAC ACC TAC ACC CAC AAC CTC
Ass Sor Vol Ph. Leu Pro Cly Lys Vol Arg Arg Lou 11e Cly Asp Ph. Cly Vol Pro Ile Sor Ile Pho Vol Not Ala Leu Ala Asp Ph. Pho Ile Lys Asp Thr Tyr Thr Cln Lys Lou
570 580 590 600
1696 MAC CT? CCC ACA CCC CT? CAC CT? ACC AA CCAZ CCC CCC CCT TCC TTC AT? CAC CCC AT? CCC ACC CCC ACC CCC T?C CCC AT? TCC AT? AT? TTC GCCC TCC CCC CT? CCC CCC CTC
Lys Vol Pro Arg Cly Leu Clu Vol Thr Ass Cly Thr Ala Arg C ly Trp Ph. I1e H is Pro Not Cly Sor Ala Thr Pro Pho Pro 11e Trp Not Not Ph. Ala Sor Pro Vol Pro Ala Lou
610 620 630 640
1816 CT? CT? TTC AT? CT? AT? TT? CT? CAC ACC CAC AT? ACC ACC CTC ATC CT? ACC AAM CCC CAC CCC MAC CT? CT? MAC CCC TCC CCC TTC CAC CT? CAC CT? CT? CT? AT? CT? CCC ATC
Leu Vol Ph. Ile Lou Ile Ph. Lou Clu Thr ClnsIle Thr Thr Lou Ile Vol Sor Lys Pro Clu Arg Lys Leu Vol Lys Cly Ser Cly Pho His Lou Asp Leu Lou Lou Ile Vol Ala NoL
650 660 670 680
1936 CCC CCC CT? CCC CCC CT? TT? CCC AT? CCC TCC CT? ACC CCC ACC ACC CT? CCC ACC ATC ACC CAC CCC MAC CCC CT? ACC CT? GCT CCT MAC ACC CCC CT? CCC CCC CAC ACC CCC CAC
Cly Cly Lou Ala Ala Lou Pho Cly Not Pro Trp Lou Sor Ala Thr Thr Vol Arg Thr Ile Thr His Ala Ass Ala Lou Thr Vol Vol Cly Lys Ser Ala Vol Pro Cly Clu Arg Ala His
690 700 710 720
2056 ATC GCT CAC CT? MAC CAC CAC CCC CT? ACC CCC CT? CT? CT? CCC GCT CT? AT? CCC CTC TCC ATC CT? AT? CAC CCC AT? CT? MAC TAC AT? CCC CT? CCC CT? CT? TT? CCC AT? T?C
Ile Vol Clu Vol Lys Clu Cln Arg Leu Sor Cly Lou Lou Vol Ala Vol Leu Ile Cly Vol Ser Ile Lou Not Clu Pro Ile Lou Lys Tyr Ile Pro Leu Ala Vol Lou Ph. Cly Ile Ph.
730 740 750 760
2176 CT? TAC AT? CCC CT? ACC TCC CT? TT? CCC AT? CAC CT? TT? CAC CCC AT? CT? CT? CT? CT? AT? CCC CCC MAC TAC CAC CCC MAC CAC CCC TAC CT? ACC CCC CT? MAC ACC TCC CCC
Leu Tyr Not Cly Vol Thr Trp Lou Ph. Cly Ile Cln Lou Ph. Asp Arg Ile Lou Leu Leu Leu Not Pro Pro Lys Tyr His Pro Lys Clu Pro Tyr Vol Thr Arg Vol Lys Thr Trp Arg
770 780 790 800
2296 AT? CAC AT? AAM AC CT? ACC CAC AT? CTC CT? CT? CCC CT? CT? TCC CCC CT? C CT?GT ACC CCC CCC TCC CT? CCC TCC CCT TT? CT? CT? CT? CT? ACC GCT CCC CT? CCC CCC cI r
Not His Ile Asnis Leu Thr Cln I1e Leu Vol Vol Ala Leu Leu Trp Cly Vol Lys Vol Sor Pro Ala Sor Lou Arg Cys Pro Ph. Vol Lou Vol Leu Thr Vol Pro Lou Arg Arg Lou810 820 830 840
2416 CT? CT? CCC CCC AT? TT? ACC CAC AT? CAC CT? AMA TCC CT? CAC ACC CAC CAC CCA CT? CT? ACA TT? CMA CAC CCC CAC CCC CAC CAC GCT TAC MAC CAC GCT CAC AT? CCC ACC TAA
Leu Lou Pro Arg Ile Ph. Ser Clu Ile Clu Leu Lys Cys Lou Asp Thr Asp Asp Ala Vol Vol Thr Ph. Clu Clu Ala Clu Cly Cln Asp Vol Tyr Ass Clu Vol Cls Net Pro Sor
2536 CCT CCC CCC CT? CCC CCA CCC ACC TCT ACA TCC ACC ACT CCC CCC CCC MAC ACC CCC CTC CT? CCC ACA CCC TCC CCC TAT CCC CCC CAC CCT CCC CCC CTA CCC AT?CMCAACA CCC ACC
2656 ACA CCC CCT ACC CCT TT? TMA CCC ACA CMA TCC CT? CCA AMA ACA CCA AAM AAA AAM AAA AAA AM AM
FIG. 1. Nucleotide sequence and predicted amino acid sequence of the chicken band 3 mRNA. The nucleotide sequence of pCHB3-1 is
shown with the nucleotide numbers in the left-hand margin. The probable translational initiation site is designated by the ATG codon at
nucleotide 1. Amino acids are numbered above each line. The boxes indicate the potential glycosylation sites at nucleotides 1723 and 2308.
The majority of this difference resides in the N-terminal
region of the molecule where an additional 89 amino acids
are predicted in mouse band 3 that are absent in chicken
band 3 (Fig. 2). Two lines of evidence suggest that transla-
tional initiation of chicken erythroid band 3 occurs at the
ATG at nucleotide 1 (Fig. 1). First the Met codon beginning
at nucleotide 1 is the first in-frame ATG downstream from
the stop codon (TAG) at nucleotide -108. Second, transla-
tion in a wheat germ extract of in vitro RNA transcripts that
extend from the 5' end of pCHB3-1 to the first BglI site (Fig.
3A) resulted in a single polypeptide of -32,000 daltons that
was immunoprecipitable with chicken erythroid band 3
antibodies (Fig. 3B, lane 2). This result is in agreement with
the predicted mass of 33,000 daltons for a polypeptide that
initiates at nucleotide 1 and terminates at the Bgll site. To
ensure that this translation product did not initiate at an ATG
upstream of nucleotide 1 and result from premature transla-
tional termination or degradation, we deleted the region from
nucleotides -705 to -14 of pCHB3-1 by excision of a 716-bp
BamHI fragment (Fig. 3A). Transcripts made in vitro from
this construct, pCHB3-1A, which extended from nucleotide
-13 to the BglI site were translated, and the resultant
polypeptides were immunoprecipitated with chicken ery-
throid band 3 antibodies. These truncated transcripts also
gave rise to a polypeptide of -32,000 daltons, (Fig. 3B, lane
3), which provides further evidence that initiation occurs at
nucleotide 1. The minor translation products of -31,000
daltons that were detected in the immunoprecipitates in Fig.
3B, lanes 2 and 3, suggested that translational initiation in
vitro also occurs at Met residue 13 (Fig. 1), whose surround-
ing sequences possess greater homology to the consensus
sequence flanking functional eucaryotic initiation sites (31)
than those surrounding Met residue 1. The predicted size of
109,000 daltons for the chicken band 3 polypeptide that
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FIG. 2. Comparison of the amino acid sequence of the chicken
erythroid band 3 polypeptides with those of the murine and human
erythroid and the human nonerythroid band 3 polypeptides. Amino
acid sequences were aligned to optimize homology, except for the
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initiates at nucleotide 1 agrees well with the estimates
obtained from sodium dodecyl sulfate-polyacrylamide gels
of 100,000 to 105,000 daltons for this protein (12, 22).
The hydropathy plot in Fig. 4 indicates that chicken
erythroid band 3 can be divided into a hydrophilic N-
terminal cytoplasmic domain and a hydrophobic C-terminal
transmembrane domain. Previous studies have shown simi-
lar results for the human (17, 20, 45, 46) and murine (30)
erythroid as well as the human nonerythroid (15) band 3
polypeptides. The truncated cytoplasmic domain of chicken
erythroid band 3 is consistent with the observation that
chicken band 3 does not bind glyceraldehyde-3-phosphate
dehydrogenase (22), which interacts with the amino terminus
of human erythroid band 3 (47). The absence of this highly
acidic N-terminal region (Fig. 2) from the chicken band 3
polypeptide also correlates with the isoelectric point of
chicken band 3, which is 1 to 2 pH units more basic than that
of human band 3 (22). In agreement with this result, se-
quence analysis reveals a net positive charge (54 basic and 40
acidic residues) for the cytoplasmic domain of chicken band
3, which extends approximately to residue 435 in Fig. 2,
while the cytoplasmic domain of murine band 3 exhibits a net
negative charge (65 acidic and 37 basic residues) (30). This
observed charge difference may result in conformational
changes in the cytoplasmic domain of chicken band 3 that
render it much more resistant to proteolysis with trypsin
than human band 3 (22).
Electron microscopic (48) and hydrodynamic (1) studies of
the cytoplasmic domain of human band 3 suggest that this
region of the molecule forms an elongated homodimer with a
pH-regulated hinge region that is rich in proline residues.
The chicken band 3 polypeptide initiates in a tryptophan-rich
region (1) just before this proline-rich region which is be-
tween residues 165 to 208 (Fig. 2). The ankyrin-binding site
of band 3 has been tentatively placed between this trypto-
phan-rich region and the pH-regulated hinge of the cytoplas-
mic domain (34). It is interesting to note that the overall
similarity between the cytoplasmic domains of chicken band
3 and murine band 3 is only 43%, while the similarity of this
putative ankyrin-binding site (between residues 124 and 164;
Fig. 2) is approximately 70o between the chicken band 3 and
the murine and human erythroid band 3 polypeptides. These
results suggest that although the sequence of the cytoplasmic
domain has diverged considerably, the sequence of the
high-affinity ankyrin-binding site has been relatively con-
served among different species.
The hydropathy plot of the chicken band 3 polypeptide
reveals 10 very hydrophobic regions (A through J in Fig. 4)
in the C-terminal portion of the molecule that are similar to
those previously demonstrated for the murine erythroid (30)
and human nonerythroid (15) band 3 polypeptides. These 10
hydrophobic regions within the transmembrane domain cor-
respond to the putative membrane-spanning segments of the
N-terminal region of the human nonerythroid band 3 polypeptide.
The numbers of the amino acids (including the inserted dashes) are
indicated in the margin to the right. The boxed regions indicate
identity between the chicken erythroid band 3 polypeptide and the
erythroid and nonerythroid band 3 polypeptides from other species.
The arrowheads after residues 592 and 596 indicate insertions in the
transmembrane domain of the human nonerythroid band 3 polypep-
tide of 25 and 3 amino acids, respectively, that are not included in
the figure. The B at residue 389 of human erythroid band 3
corresponds to Asn or Asp. CHB3, Chicken erythroid band 3; MB3,
murine erythroid band 3; HB3, human erythroid band 3; and
HNEB3, human nonerythroid band 3.
















9 D D 39 g9 X Bg R 30-
P ,Bg qg Sq X 3g
14.3-
200 bp B
FIG. 3. In vitro translation and immunoprecipitation with band 3 antibodies of truncated band 3 polypeptides. Transcripts were
synthesized in vitro with SP6 RNA polymerase from pCHB3-1 and pCHB3-1A templates (prepared as described in Materials and Methods)
that were linearized with restriction endonuclease BgI (A). These transcripts, which terminate at the BgII site indicated by the arrows (A),
were translated in vitro in a wheat germ extract in the presence of 0.2 mCi of [35S]methionine per ml, and the resulting polypeptides were
immunoprecipitated with band 3 antibodies (B). The band 3 immunoprecipitates resulting from the translation of pCHB3-1 transcripts (lane
2), pCHB3-1A transcripts (lane 3), and a no RNA control (lane 1) were analyzed by electrophoresis on a sodium dodecyl sulfate-15%
polyacrylamide gel. The migration of '4C-labeled molecular mass markers (phosphorylase b, 92,500 daltons (92.5 kD); bovine serum albumin,
69,000 daltons; ovalbumin, 46,000 daltons; carbonic anhydrase, 30,000 daltons; and lysozyme, 14,300 daltons) is indicated in the margin to
the left. Abbreviations in the restriction maps are: PL, polylinker; B, BamHI; R, EcoRI; P, PvuII, Bg, BglI; BgII, BglII; X, XhoI; PROM,
promoter.
polypeptide. Hydrophobic peaks A, C, E, and G (Fig. 4) are
composed primarily of hydrophobic amino acids and fit the
criteria for single membrane-spanning a-helical structures
(18). Hydrophobic peaks D and F (Fig. 4) contain both
hydrophilic and hydrophobic amino acids and are predicted
to form single membrane-spanning amphipathic helices with
all the polar residues on one face of the helix. Hydrophobic
peak B is similarly composed of hydrophilic and hydropho-
bic residues and is predicted to form an amphipathic helix
which spans the membrane two times, consistent with the
model proposed for murine erythroid band 3 (30). Recent
experiments with monoclonal antibodies have demonstrated
that lysine 772 (Fig. 2) is susceptible to intracellular cleavage
with trypsin (25). This result necessitates that hydrophobic
peak H (Fig. 4) spans the membrane two times or not at all
to maintain the proper orientation of the band 3 polypeptide
in the membrane. The highly hydrophobic nature of peak H
suggests that this region indeed traverses the membrane two
times in an a-helical structure which turns within the mem-
brane at proline 751 (Fig. 2). Since no topological data are
available for the extreme C terminus of the band 3 polypep-
tide it is not possible at present to predict the number of
times hydrophobic regions I and J (Fig. 4) cross the mem-
brane.
The similarity observed in the hydropathy plots of the
band 3 polypeptides from different species is consistent with
the high degree of conservation at the sequence level. The
transmembrane domain of the chicken band 3 polypeptide is
79% similar to the murine erythroid and 71% similar to the
human nonerythroid band 3 polypeptides (residue 435 to C
terminus; Fig. 2). Chicken band 3 also exhibits 75% similar-
ity to those regions of the transmembrane domain of human
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FIG. 4. Hydropathy plot of the predicted amino acid sequence of the chicken erythroid band 3 polypeptide obtained from the nucleotide
sequence of pCHB3-1. The plots were made by using the algorithm of Kyte and Doolittle (32). Hydrophobicity values were averaged over
a window of seven amino acids. Hydrophobic regions in the sequence are designated A to J. The arrowheads at residues 334 and 358 indicate
the boundaries of the region that is present in pCHB3-1 and absent in pCHB3-2. Note that this region almost exactly corresponds to
hydrophobic region F.
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erythroid band 3 that have been sequenced (8, 35). Further-
more, various topological features that have been elucidated
by chemical modification of the transmembrane domain of
human erythroid band 3 are conserved among the different
band 3 polypeptides. There are two potential glycosylation
sites (Asn-X-Ser/Thr) in chicken erythroid band 3 at residues
671 and 866 (Fig. 2). The site at residue 671 is conserved in
murine band 3 and maps closely to the glycosylation site
identified in the human erythroid band 3 polypeptide (23).
Since the topology of the band 3 polypeptide at the C
terminus is not known it is unclear whether the glycosylation
site at residue 866 is utilized in the chicken molecule. Three
extracellular lysines have been identified in the human band
3 polypeptide (8, 35), two of which (residues 460 and 569;
Fig. 2) are conserved in the chicken polypeptide, while the
third (residue 572) is not. Chemical modification experiments
have demonstrated that either lysine 569 or 572 in the human
erythroid polypeptide is modified by di-iodosulphophenyl
isothiocyanate (H2DIDS), an inhibitor of anion transport
(35). H2DIDS-sensitive sites have been suggested to be
high-affinity chloride-binding sites in human band 3. These
results suggest that lysine residue 569 provides one of the
high-affinity chloride-binding sites in the chicken band 3
polypeptide.
A 72-amino-acid peptide fragment from human erythroid
band 3 has been shown to contain an internal lysine (residue
619; Fig. 2) that is modified by phenylisothiocyanate (PITC),
which blocks anion transport (8). This lysine is not con-
served in the chicken erythroid band 3 polypeptide. This
suggests that the PITC modification of lysine residue 619
blocks anion transport by steric inhibition rather than inter-
acting with an essential residue for the transport process.
Tyrosine residue 657 (Fig. 2) in this peptide fragment is
susceptible to extracellular radioiodination (8) and is con-
served among the band 3 polypeptides from different spe-
cies. Finally, modification of carboxylic groups in this region
of the polypeptide inactivates anion exchange (6). Three
aspartate residues (636, 650, and 655; Fig. 2) are conserved
among the chicken and human erythroid and human nonery-
throid band 3 polypeptides, although aspartate 655 has
diverged in the murine sequence. This result suggests that
aspartate residue 636 or 650 is important in the exchange
process.
It is interesting to note that nine of the membrane-
spanning segments of the chicken band 3 polypeptide are
bound internally or externally by arginine residues and that
each of these residues is conserved in either the murine
erythroid or human nonerythroid polypeptide. Chemical
modification (51, 53) and pH titration (50) experiments have
indicated that arginine residues in the 35,000-dalton chymo-
tryptic fragment of the membrane domain of human ery-
throid band 3 are involved in anion exchange. The location
of these arginine residues in the membrane-spanning seg-
ments of the chicken band 3 polypeptide suggests that one or
more of these residues provides additional high-affinity C1--
binding sites for the chicken band 3 polypeptide.
Human erythroid band 3 has been shown to exist as a
dimer in solution in the presence of nonionic detergents (52).
This interaction is mediated by the transmembrane domain
since the removal of the cytoplasmic domain by proteolysis
does not affect dimerization (41). This dimerization of the
transmembrane domain could presumably be mediated by
disulfide linkages. Sequence comparison reveals that two
cysteine residues (509 and 914; Fig. 2) in the transmembrane
domain are conserved among the chicken and murine ery-
throid and human nonerythroid band 3 polypeptides. A third
residue (435; Fig. 2) is conserved between the chicken
erythroid and human nonerythroid polypeptides, while three
additional cysteines are present in the chicken polypeptide
that have diverged from the mouse and human sequences.
Future structural studies will be required to determine
whether any of these cysteines in the transmembrane do-
main of the chicken band 3 polypeptide are involved in
intermolecular or intramolecular disulfide bonding.
A variant of the chicken erythroid anion transporter that
lacks a putative transmembrane-spanning segment. Analysis
of additional band 3 cDNA clones isolated from the Agtll
chicken erythroid cDNA library revealed that a partial
cDNA clone of approximately 1.3 kilobases, pCHB3-2,
yielded a different restriction map than pCHB3-1. Subse-
quent sequence analysis revealed that pCHB3-2 initiated at
nucleotide 763 of pCHB3-1 and extended to nucleotide 2030
(Fig. 1). However, pCHB3-2 contained an in-frame deletion
of 75 nucleotides in the transmembrane domain of the
chicken band 3 polypeptide. This deletion encompassed
nucleotides 1601 to 1675 that encode amino acids 534 to 558
in pCHB3-1 (Fig. 1), which corresponds to residues 630 to
654 in Fig. 2. The arrows on the hydropathy plot in Fig. 4
indicate that the deletion in pCHB3-2 almost exactly corre-
sponds to the membrane-spanning segment represented by
hydrophobic peak F. To ensure that pCHB3-2 is represented
in the erythroid RNA population rather than simply resulting
from an artifact of cloning, we performed S1 nuclease
analysis to examine the 5' and 3' boundaries of the deletion.
Total erythroid RNA from erythroid cells isolated from 5-,
8-, 10-, and 15-day-old chicken embryos was hybridized to
probes end labeled with 32P at the BgIII site (Fig. 5A) and the
XhoI site (Fig. SB) as indicated in Fig. SC. S1 nuclease
digestion of the resulting hybrids yielded full-length pro-
tected fragments of 656 bp (Fig. SA) and 1,070 bp (Fig. SB),
representing the RNA species complementary to pCHB3-2,
as well as the 225-bp fragment (Fig. SA) and the 164-bp
fragment (Fig. SB) that would be predicted from hybridiza-
tion to the RNA species complementary to pCHB3-1. The
origin of the additional bands in Fig. SB is at this time
unknown. The RNA complementary to pCHB3-2 accumu-
lated during embryonic development in a fashion similar to
that previously reported for the RNA complementary to
pCHB3-1 (13). Furthermore, analysis of poly(A)+ RNA from
5-day-old erythroid cells by similar methods (Fig. SA) indi-
cated that the transcripts complementary to pCHB3-1 and
pCHB3-2 are represented in poly(A)+ RNA to the same
extent as they are in total erythroid RNA. These results
indicate that RNA transcripts that encode band 3 polypep-
tides with alternative primary structures in their transmem-
brane domain are present in chicken erythroid cells.
DISCUSSION
In this report, we described the cloning and characteriza-
tion of the chicken erythroid anion transporter (band 3).
Analysis of the band 3 cDNA clones revealed several
features of chicken erythroid band 3 that are unique among
previously characterized band 3 polypeptides, as well as the
highly conserved nature of the transmembrane domain of
this polypeptide among different species. Furthermore, we
described for the first time the characterization of a band 3
polypeptide with alternative primary structures in its mem-
brane-spanning segments.
Sequencing studies in conjunction with primer extension
analyses indicated that the chicken erythroid band 3 mRNA
contains a very long 5' untranslated region of -1.5 kilobases
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FIG. 5. Steady-state levels of erythroid band 3 RNA determined
by S1 nuclease protection assays. A total of 2 x 106 cell equivalents
of total RNA from erythroid cells isolated from 5-, 8-, 10-, and
15-day-old chicken embryos were hybridized with either a 32P-end-
labeled BglII-EcoRI fragment (A) or a 32P-end-labeled XhoI-PvuII
fragment (B) from pCHB3-2 for 12 h at 55°C. The 32P-end-labeled
BglII-EcoRI fragment was also hybridized to 200 ng of poly(A)+
RNA from 5-day-old erythroid cells for 12 h at 55°C (A). The
samples were digested with S1 nuclease for 30 min at 30°C, and the
fragments were resolved on a 7 M urea-5% polyacrylamide gel.
Lane C, No RNA control. The protected fragments from each
hybridization correspond to those predicted from hybridization of
probes A and B to RNA species homologous to pCHB3-1 (225 and
164 bp, respectively, marked by arrowheads in panels A and B) and
pCHB3-2 (656 and 1,070 bp, respectively, marked by arrows in
panels A and B) as illustrated in panel C. Size markers in base pairs
are several end-labeled restriction fragments of Hinfi-digested
pBR322 DNA. Abbreviations in the restriction map are: R, EcoRI;
P, PvuII; Bg, BgII; BgII, BglII; and X, XhoI.
and a 3' untranslated region of only 177 bp. Although there
is no consensus polyadenylation signal in the 3' untranslated
region of pCHB3-1 (Fig. 1), multiple cDNA clones have been
isolated and sequenced and all terminated at the same
poly(A) tract, suggesting that this is the true 3' terminus of
the molecule. The structure of the chicken erythroid band 3
mRNA is different from that observed for the murine band 3
mRNA species, which has been shown to contain a 121-bp 5'
untranslated region and a 1,470-bp 3' untranslated region
(30). Whether this difference in RNA structure seen between
the chicken and murine erythroid band 3 RNAs affects
factors such as RNA processing, transport, or stability
during erythroid development awaits further analysis.
The N terminus of the chicken erythroid band 3 polypep-
tide is -90 amino acids shorter than that of the murine (30)
and the human (26) erythroid band 3 polypeptides. This
truncated chicken band 3 polypeptide is consistent with the
absence of binding to glyceraldehyde-3-phosphate dehydro-
genase (22), which associates with the extreme N terminus
of the human erythroid band 3 polypeptide (47). In addition,
the loss of this very acidic N-terminal region accounts for the
relatively basic isoelectric point observed for chicken ery-
throid band 3 (22). Comparison of the sequence of the
cytoplasmic domain of chicken and murine erythroid band 3
polypeptides indicates that the degree of conservation is
relatively low. However, the region where the high-affinity
ankyrin-binding site has tentatively been placed (34) exhibits
greater than 70o identity between the chicken erythroid and
the murine and human erythroid band 3 polypeptides. In
addition, regions of the human nonerythroid band 3 polypep-
tide (residues 98 to 121 and 142 to 153; Fig. 2) also possess
considerable similarity to this putative ankyrin-binding site,
suggesting that this site is conserved not only in erythroid
but also in nonerythroid cell types.
The transmembrane domain of chicken erythroid band 3 is
highly homologous to the transmembrane domains of the
murine erythroid and human nonerythroid band 3 polypep-
tides. Each of these polypeptides possesses 10 hydrophobic
regions which potentially span the membrane 12 to 14 times.
Four of these regions (peaks A, C, E, and G; Fig. 4) are
predicted to span the membrane a single time in an a-helical
structure, consistent with the model for murine erythroid
band 3 (30). The recent demonstration that lysine 772 (Fig. 2)
is intracellular (25) requires that hydrophobic peak H (Fig. 4)
spans the membrane twice or not at all to maintain the
proper topology of the band 3 polypeptide in the lipid
bilayer. The highly hydrophobic nature of peak H suggests
that it traverses the membrane two times, unlike the model
for murine band 3 which proposes a single membrane-
spanning segment (30). Two of the hydrophobic regions (D
and F; Fig. 4) are predicted to cross the membrane once as
amphipathic helices, whereas region B crosses the mem-
brane two times as an amphipathic helix. Since it is not
known whether the C terminus of the band 3 polypeptide is
internal or external it is not possible to predict with certainty
the number of times hydrophobic peaks I and J cross the
membrane (Fig. 4). However, given that both peaks are very
broad (20 to 24 amino acids per membrane-spanning seg-
ment), it is possible that each traverses the membrane two
times as an amphipathic helix, resulting in 14 membrane-
spanning segments with the C terminus being intracellular.
Additional biochemical and structural studies will be re-
quired to assess the validity of this model for the topology of
the band 3 polypeptide.
The demonstration of RNA transcripts in chicken ery-
throid cells that encode variant band 3 polypeptides provides
the first example of a transporter protein or an ion channel
that exhibits alternative primary structures in its membrane-
spanning segments. DNA sequencing and S1 analyses
showed that the RNA complementary to pCHB3-2 lacks
amino acids 534 to 558 of pCHB3-1, which corresponds
almost exactly to hydrophobic peak F of the hydropathy
plot. Recent studies have demonstrated that the chicken
erythroid band 3 polypeptide is composed of at least two
variants of -100,000 and -105,000 daltons, both of which
label with H2DIDS (12, 24). Pulse-chase studies have further
shown that these variant band 3 polypeptides arise through
the posttranslational modification of -95,000- and -97,000-
dalton primary translation products (13). The 25-amino-acid
segment that is absent in the polypeptide corresponding to
pCHB3-2 suggests the possibility that pCHB3-2 corresponds
to the -95,000-dalton translation product. Examination of
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the structure and organization of the murine band 3 gene (29)
has revealed that one of the intron-exon splice junctions of
this gene exactly matches the 5' boundary of the deletion in
pCHB3-2. The 3' boundary of the deletion in pCHB3-2 is 14
nucleotides 5' to the next intron-exon splice junction in the
murine band 3 gene. This strongly suggests that the equiva-
lent of murine exon 15 in the chicken gene is removed from
the RNA corresponding to pCHB3-2 by alternative splicing.
This hypothesis is further supported by the fact that the
murine (29) and probably the chicken (12) band 3 polypep-
tides are encoded by a single gene. The human nonerythroid
band 3 polypeptide contains two hydrophilic insertions (ar-
rowheads, Fig. 2) of 25 and 3 amino acids that are probably
extracellular and are not found in the chicken or murine
erythroid band 3 polypeptides. These two insertions may
also result from alternative splicing of the human nonery-
throid band 3 RNA.
At present, it is not known whether the polypeptide
encoded by pCHB3-2 stably accumulates in the membrane
of chicken erythroid cells, although the transcript comple-
mentary to pCHB3-2 accumulates in the same manner as
that complementary to pCHB3-1 during chicken embryonic
development. The levels of the two RNA species detected
by Si nuclease assays (Fig. 5) do not reflect their relative
abundance. Additional experiments have indicated that the
RNA complementary to pCHB3-1 is much more abundant
than the RNA complementary to pCHB3-2 at all stages of
development examined (data not shown).
The stable accumulation of the polypeptide encoded by
pCHB3-2 in the erythrocyte membrane would not necessar-
ily indicate that this polypeptide could act as a functional
anion transporter. A current anion transport model has
proposed that the helical membrane-spanning segments of
band 3 cluster such that all the charged residues of the
amphipathic helices are facing the interior of an aqueous
pore, as has been proposed for other transport proteins (18,
19). The positively charged residues of band 3 on the interior
and exterior of the lipid bilayer would then act to funnel
anions to the high-affinity binding site within this membra-
nous pore (24). The region corresponding to hydrophobic
peak F is one of the few segments of the band 3 polypeptide
that has been clearly demonstrated to span the membrane
(8). Furthermore, this region is flanked by the external
glycosylation site at residue 671 (Fig. 2) and the region
corresponding to hydrophobic peak E, which has also been
shown to span the membrane (8, 35). The effect of removing
the membrane-spanning segment corresponding to hydro-
phobic peak F on the folding pattern and topology of the
band 3 polypeptide and ultimately on its anion transport
activity remains to be established. However, the possibility
exists that removal of this transmembrane segment results in
a band 3 polypeptide which has lost its capacity to exchange
anions.
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